Extended Data Fig. 3: TCRγδ clonality assessments by mRNA sequencing of tumor samples before and after surgical resection.
From: Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma

a,b, Charts showing the number of TRG (a) and TRD clones (b) detected in pre- and postsurgical samples of patients from the neoadjuvant nivolumab and control groups. Only cases with detectable TRD sequences are shown. P values were obtained using paired two-tailed Wilcoxon rank-sum tests and corrected with Benjamini–Hochberg method and are indicated above each graph. ns, not significant (P < 0.05).